Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q3 2025 ▲▼ | Q4 2025 ▲▼ | Change ▲▼ | Q3 2025 ▲▼ | Q4 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Stoke Therapeutics, Inc.(STOK) | 5,404,674 | 5,404,674 | 0 | $109.88M | $171.54M | 34.73% | +$61.66M |
| GH Research PLC(GHRS) | 8,601,189 | 10,406,575 | +1,805,386 | $104.31M | $132.16M | 26.75% | +$27.85M |
| Cullinan Therapeutics, Inc.(CGEM) | 5,766,090 | 8,963,500 | +3,197,410 | $34.19M | $92.77M | 18.78% | +$58.58M |
| Denali Therapeutics Inc.(DNLI) | 261,687 | 1,738,750 | +1,477,063 | $3.80M | $28.71M | 5.81% | +$24.91M |
| C4 Therapeutics, Inc.(CCCC) | 7,098,133 | 7,098,133 | 0 | $15.76M | $13.56M | 2.74% | -$2.20M |
| Xencor, Inc.(XNCR) | 0 | 705,558 | +705,558 | $0 | $10.80M | 2.19% | +$10.80M |
| Immatics N.V.SHS(IMTX) | 0 | 921,950 | +921,950 | $0 | $9.68M | 1.96% | +$9.68M |
| TScan Therapeutics, Inc.(TCRX) | 7,857,347 | 8,019,148 | +161,801 | $14.30M | $8.02M | 1.62% | -$6.28M |
| Passage Bio, Inc.(PASG) | 623,704 | 623,704 | 0 | $5.01M | $7.36M | 1.49% | +$2.35M |
| Korro Bio, Inc.(KRRO) | 0 | 677,915 | +677,915 | $0 | $5.43M | 1.10% | +$5.43M |
| Precision BioSciences, Inc.(DTIL) | 1,042,596 | 993,913 | -48,683 | $5.76M | $4.13M | 0.84% | -$1.62M |
| Neuphoria Therapeutics Inc | 0 | 875,228 | +875,228 | $0 | $3.40M | 0.69% | +$3.40M |
| Agios Pharmaceuticals, Inc.(AGIO) | 0 | 79,624 | +79,624 | $0 | $2.17M | 0.44% | +$2.17M |
| CG Oncology, Inc.(CGON) | 0 | 31,591 | +31,591 | $0 | $1.31M | 0.27% | +$1.31M |
| Arrowhead Pharmaceuticals, Inc.(ARWR) | 0 | 12,043 | +12,043 | $0 | $799.5K | 0.16% | +$799.5K |
| Design Therapeutics, Inc.(DSGN) | 65,954 | 69,516 | +3,562 | $496.6K | $652.1K | 0.13% | +$155.4K |
| Entrada Therapeutics, Inc.(TRDA) | 0 | 51,689 | +51,689 | $0 | $531.4K | 0.11% | +$531.4K |
| Werewolf Therapeutics, Inc.(HOWL) | 0 | 655,926 | +655,926 | $0 | $415.5K | 0.08% | +$415.5K |
| MapLight Therapeutics, Inc.(MPLT) | 0 | 13,477 | +13,477 | $0 | $236.7K | 0.05% | +$236.7K |
| Generation Bio Co | 0 | 25,000 | +25,000 | $0 | $142.0K | 0.03% | +$142.0K |
| Proqr Thrapeutics N VSHS EURO SHS EURO | 0 | 68,486 | +68,486 | $0 | $138.3K | 0.03% | +$138.3K |
| Applied Therapeutics Inc | 0 | 410,500 | +410,500 | $0 | $41.0K | 0.01% | +$41.0K |
| ADC Therapeutics SASHS(ADCT) | 1,325,848 | 0 | -1,325,848 | $5.30M | $0 | — | -$5.30M |
| Allogene Therapeutics Inc | 546,119 | 0 | -546,119 | $677.2K | $0 | — | -$677.2K |
| iBio, Inc.(IBIO) | 1,055,897 | 0 | -1,055,897 | $874.1K | $0 | — | -$874.1K |
| Merus N V | 1,534,141 | 0 | -1,534,141 | $144.44M | $0 | — | -$144.44M |
| Protagonist Therapeutics Inc | 700,014 | 0 | -700,014 | $46.50M | $0 | — | -$46.50M |